MIMPARA is a leading medication used for the treatment of hyperparathyroidism, specifically in patients undergoing dialysis for chronic kidney disease. With active ingredients like cinacalcet, MIMPARA works primarily by reducing the levels of parathyroid hormone, calcium, and phosphorus in the body. It’s proven to be a crucial tool in managing these conditions, contributing to better overall patient health.